SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-21-002520
Filing Date
2021-02-11
Accepted
2021-02-11 09:21:54
Documents
9
Period of Report
2021-02-08
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K govx20210209_8k.htm 8-K 34294
2 EXHIBIT 1.01 ex_225406.htm EX-1.01 355844
3 EXHIBIT 5.1 ex_225407.htm EX-5.1 14620
4 EXHIBIT 10.1 ex_225848.htm EX-10.1 119516
5 EXHIBIT 99.1 ex_225408.htm EX-99.1 11460
6 logo01.jpg GRAPHIC 13993
7 womblelogo01.jpg GRAPHIC 6743
8 womblelogo02.jpg GRAPHIC 13189
9 womblelogo03.jpg GRAPHIC 10996
  Complete submission text file 0001437749-21-002520.txt   599007
Mailing Address 1900 LAKE PARK DRIVE SUITE 380 SMYRNA GA 30080
Business Address 1900 LAKE PARK DRIVE SUITE 380 SMYRNA GA 30080 678-384-7220
GeoVax Labs, Inc. (Filer) CIK: 0000832489 (see all company filings)

IRS No.: 870455038 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39563 | Film No.: 21617129
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences